BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38196335)

  • 1. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
    Garland EL; Nakamura Y; Bryan CJ; Hanley AW; Parisi A; Froeliger B; Marchand WR; Donaldson GW
    Am J Psychiatry; 2024 Feb; 181(2):125-134. PubMed ID: 38196335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
    Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
    JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
    Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
    J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
    Garland EL; Fix ST; Hudak JP; Bernat EM; Nakamura Y; Hanley AW; Donaldson GW; Marchand WR; Froeliger B
    Psychol Med; 2023 Apr; 53(5):2085-2094. PubMed ID: 37310337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects.
    Parisi A; Hanley AW; Garland EL
    Behav Res Ther; 2022 May; 152():104066. PubMed ID: 35248875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
    Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
    J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity.
    Hanley AW; Garland EL
    Drug Alcohol Depend; 2020 Dec; 217():108351. PubMed ID: 33070057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
    Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
    Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness-induced self-transcendence promotes universal love with consequent effects on opioid misuse.
    Garland EL; Jinpa T
    Behav Res Ther; 2024 Apr; 175():104494. PubMed ID: 38395015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
    Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.
    Garland EL; Howard MO
    Drug Alcohol Depend; 2014 Nov; 144():283-7. PubMed ID: 25282309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
    Garland EL; Froeliger B; Howard MO
    Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.
    Cooperman NA; Hanley AW; Kline A; Garland EL
    J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain: A Randomized Clinical Trial.
    Cooperman NA; Lu SE; Hanley AW; Puvananayagam T; Dooley-Budsock P; Kline A; Garland EL
    JAMA Psychiatry; 2024 Apr; 81(4):338-346. PubMed ID: 38061786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoom-Based Mindfulness-Oriented Recovery Enhancement Plus Just-in-Time Mindfulness Practice Triggered by Wearable Sensors for Opioid Craving and Chronic Pain.
    Garland EL; Gullapalli BT; Prince KC; Hanley AW; Sanyer M; Tuomenoksa M; Rahman T
    Mindfulness (N Y); 2023 May; ():1-17. PubMed ID: 37362184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study.
    Garland EL; Bryan MA; Priddy SE; Riquino MR; Froeliger B; Howard MO
    Ann Behav Med; 2019 Aug; 53(10):865-876. PubMed ID: 30668631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial.
    Vowles KE; Witkiewitz K; Cusack KJ; Gilliam WP; Cardon KE; Bowen S; Edwards KA; McEntee ML; Bailey RW
    J Pain; 2020; 21(7-8):798-807. PubMed ID: 31760109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
    Vowles KE; Witkiewitz K; Clarke E; Schmidt Z; Borsari B; Edwards KE; Korecki JR; Moniz-Lewis DI; Bondzie JA; Mullins C; Thoreson CI; Delacruz J; Wilkins CH; Nelson S; Delventura J; Henderson R; Katz A; Hua W; Watson E; Baxley C; Canlas BR; Pendleton T; Herbst E; Batki S
    Contemp Clin Trials; 2023 Mar; 126():107096. PubMed ID: 36693589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy.
    Parisi A; Landicho HL; Hudak J; Leknes S; Froeliger B; Garland EL
    Drug Alcohol Depend; 2022 Apr; 233():109361. PubMed ID: 35278786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.